A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
NG101m Adjuvant Therapy in Glioblastoma Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3